Medical qualification of a commercial spaceflight participant: Not your average astronaut

Richard T. Jennings, David M F Murphy, David L. Ware, Serena M. Aunon, Richard E. Moon, Valery V. Bogomolov, Valeri V. Morgun, Yuri I. Voronkov, Caroline E. Fife, Michael Boyars, Randy D. Ernst

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background: Candidates for commercial spaceflight may be older than the typical astronaut and more likely to have medical problems that place them at risk during flight. Since the effects of microgravity on many medical conditions are unknown, physicians have little guidance when evaluating and certifying commercial spaceflight participants. This dynamic new era in space exploration may provide important data for evaluating medical conditions, creating appropriate medical standards, and optimizing treatment alternatives for long-duration spaceflight. Case: A 57-yr-old spaceflight participant for an ISS mission presented with medical conditions that included moderately severe bullous emphysema, previous spontaneous pneumothorax with talc pleurodesis, a lung parenchymal mass, and ventricular and atrial ectopy. The medical evaluation required for certification was extensive and included medical studies and monitoring conducted in analogue spaceflight environments including altitude chambers, high altitude mixed-gas simulation, zero-G aircraft, and high-G centrifuge. To prevent recurrence of pneumothorax, we performed video-assisted thoracoscopic pleurodesis, and to assess lung masses, several percutaneous or direct biopsies. The candidate's 10-d mission was without incident. Conclusion: Non-career astronauts applying for commercial suborbital and orbital spaceflight will, at least in the near future, challenge aerospace physicians with unknowns regarding safety during training and flight, and highlight important ethical and risk-assessment problems. The information obtained from this new group of space travelers will provide important data for the evaluation and in-flight treatment of medical problems that space programs have not yet addressed systematically, and may improve the medical preparedness of exploration-class missions.

Original languageEnglish (US)
Pages (from-to)475-484
Number of pages10
JournalAviation Space and Environmental Medicine
Volume77
Issue number5
StatePublished - May 2006

Fingerprint

Astronauts
Space Flight
Medical problems
Talc
Biopsy
Microgravity
Centrifuges
Risk assessment
Pleurodesis
Aircraft
Pneumothorax
Monitoring
Gases
Physicians
Weightlessness
Lung
Emphysema
Certification
Safety
Recurrence

Keywords

  • Emphysema
  • Pleurodesis
  • Pneumothorax
  • Spaceflight
  • Ventricular ectopy

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Pollution
  • Medicine(all)

Cite this

Jennings, R. T., Murphy, D. M. F., Ware, D. L., Aunon, S. M., Moon, R. E., Bogomolov, V. V., ... Ernst, R. D. (2006). Medical qualification of a commercial spaceflight participant: Not your average astronaut. Aviation Space and Environmental Medicine, 77(5), 475-484.

Medical qualification of a commercial spaceflight participant : Not your average astronaut. / Jennings, Richard T.; Murphy, David M F; Ware, David L.; Aunon, Serena M.; Moon, Richard E.; Bogomolov, Valery V.; Morgun, Valeri V.; Voronkov, Yuri I.; Fife, Caroline E.; Boyars, Michael; Ernst, Randy D.

In: Aviation Space and Environmental Medicine, Vol. 77, No. 5, 05.2006, p. 475-484.

Research output: Contribution to journalArticle

Jennings, RT, Murphy, DMF, Ware, DL, Aunon, SM, Moon, RE, Bogomolov, VV, Morgun, VV, Voronkov, YI, Fife, CE, Boyars, M & Ernst, RD 2006, 'Medical qualification of a commercial spaceflight participant: Not your average astronaut', Aviation Space and Environmental Medicine, vol. 77, no. 5, pp. 475-484.
Jennings RT, Murphy DMF, Ware DL, Aunon SM, Moon RE, Bogomolov VV et al. Medical qualification of a commercial spaceflight participant: Not your average astronaut. Aviation Space and Environmental Medicine. 2006 May;77(5):475-484.
Jennings, Richard T. ; Murphy, David M F ; Ware, David L. ; Aunon, Serena M. ; Moon, Richard E. ; Bogomolov, Valery V. ; Morgun, Valeri V. ; Voronkov, Yuri I. ; Fife, Caroline E. ; Boyars, Michael ; Ernst, Randy D. / Medical qualification of a commercial spaceflight participant : Not your average astronaut. In: Aviation Space and Environmental Medicine. 2006 ; Vol. 77, No. 5. pp. 475-484.
@article{c0a35934faf6435e8041574b9839561d,
title = "Medical qualification of a commercial spaceflight participant: Not your average astronaut",
abstract = "Background: Candidates for commercial spaceflight may be older than the typical astronaut and more likely to have medical problems that place them at risk during flight. Since the effects of microgravity on many medical conditions are unknown, physicians have little guidance when evaluating and certifying commercial spaceflight participants. This dynamic new era in space exploration may provide important data for evaluating medical conditions, creating appropriate medical standards, and optimizing treatment alternatives for long-duration spaceflight. Case: A 57-yr-old spaceflight participant for an ISS mission presented with medical conditions that included moderately severe bullous emphysema, previous spontaneous pneumothorax with talc pleurodesis, a lung parenchymal mass, and ventricular and atrial ectopy. The medical evaluation required for certification was extensive and included medical studies and monitoring conducted in analogue spaceflight environments including altitude chambers, high altitude mixed-gas simulation, zero-G aircraft, and high-G centrifuge. To prevent recurrence of pneumothorax, we performed video-assisted thoracoscopic pleurodesis, and to assess lung masses, several percutaneous or direct biopsies. The candidate's 10-d mission was without incident. Conclusion: Non-career astronauts applying for commercial suborbital and orbital spaceflight will, at least in the near future, challenge aerospace physicians with unknowns regarding safety during training and flight, and highlight important ethical and risk-assessment problems. The information obtained from this new group of space travelers will provide important data for the evaluation and in-flight treatment of medical problems that space programs have not yet addressed systematically, and may improve the medical preparedness of exploration-class missions.",
keywords = "Emphysema, Pleurodesis, Pneumothorax, Spaceflight, Ventricular ectopy",
author = "Jennings, {Richard T.} and Murphy, {David M F} and Ware, {David L.} and Aunon, {Serena M.} and Moon, {Richard E.} and Bogomolov, {Valery V.} and Morgun, {Valeri V.} and Voronkov, {Yuri I.} and Fife, {Caroline E.} and Michael Boyars and Ernst, {Randy D.}",
year = "2006",
month = "5",
language = "English (US)",
volume = "77",
pages = "475--484",
journal = "Aerospace medicine and human performance",
issn = "2375-6314",
publisher = "Aerospace Medical Association",
number = "5",

}

TY - JOUR

T1 - Medical qualification of a commercial spaceflight participant

T2 - Not your average astronaut

AU - Jennings, Richard T.

AU - Murphy, David M F

AU - Ware, David L.

AU - Aunon, Serena M.

AU - Moon, Richard E.

AU - Bogomolov, Valery V.

AU - Morgun, Valeri V.

AU - Voronkov, Yuri I.

AU - Fife, Caroline E.

AU - Boyars, Michael

AU - Ernst, Randy D.

PY - 2006/5

Y1 - 2006/5

N2 - Background: Candidates for commercial spaceflight may be older than the typical astronaut and more likely to have medical problems that place them at risk during flight. Since the effects of microgravity on many medical conditions are unknown, physicians have little guidance when evaluating and certifying commercial spaceflight participants. This dynamic new era in space exploration may provide important data for evaluating medical conditions, creating appropriate medical standards, and optimizing treatment alternatives for long-duration spaceflight. Case: A 57-yr-old spaceflight participant for an ISS mission presented with medical conditions that included moderately severe bullous emphysema, previous spontaneous pneumothorax with talc pleurodesis, a lung parenchymal mass, and ventricular and atrial ectopy. The medical evaluation required for certification was extensive and included medical studies and monitoring conducted in analogue spaceflight environments including altitude chambers, high altitude mixed-gas simulation, zero-G aircraft, and high-G centrifuge. To prevent recurrence of pneumothorax, we performed video-assisted thoracoscopic pleurodesis, and to assess lung masses, several percutaneous or direct biopsies. The candidate's 10-d mission was without incident. Conclusion: Non-career astronauts applying for commercial suborbital and orbital spaceflight will, at least in the near future, challenge aerospace physicians with unknowns regarding safety during training and flight, and highlight important ethical and risk-assessment problems. The information obtained from this new group of space travelers will provide important data for the evaluation and in-flight treatment of medical problems that space programs have not yet addressed systematically, and may improve the medical preparedness of exploration-class missions.

AB - Background: Candidates for commercial spaceflight may be older than the typical astronaut and more likely to have medical problems that place them at risk during flight. Since the effects of microgravity on many medical conditions are unknown, physicians have little guidance when evaluating and certifying commercial spaceflight participants. This dynamic new era in space exploration may provide important data for evaluating medical conditions, creating appropriate medical standards, and optimizing treatment alternatives for long-duration spaceflight. Case: A 57-yr-old spaceflight participant for an ISS mission presented with medical conditions that included moderately severe bullous emphysema, previous spontaneous pneumothorax with talc pleurodesis, a lung parenchymal mass, and ventricular and atrial ectopy. The medical evaluation required for certification was extensive and included medical studies and monitoring conducted in analogue spaceflight environments including altitude chambers, high altitude mixed-gas simulation, zero-G aircraft, and high-G centrifuge. To prevent recurrence of pneumothorax, we performed video-assisted thoracoscopic pleurodesis, and to assess lung masses, several percutaneous or direct biopsies. The candidate's 10-d mission was without incident. Conclusion: Non-career astronauts applying for commercial suborbital and orbital spaceflight will, at least in the near future, challenge aerospace physicians with unknowns regarding safety during training and flight, and highlight important ethical and risk-assessment problems. The information obtained from this new group of space travelers will provide important data for the evaluation and in-flight treatment of medical problems that space programs have not yet addressed systematically, and may improve the medical preparedness of exploration-class missions.

KW - Emphysema

KW - Pleurodesis

KW - Pneumothorax

KW - Spaceflight

KW - Ventricular ectopy

UR - http://www.scopus.com/inward/record.url?scp=33646487126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646487126&partnerID=8YFLogxK

M3 - Article

C2 - 16708526

AN - SCOPUS:33646487126

VL - 77

SP - 475

EP - 484

JO - Aerospace medicine and human performance

JF - Aerospace medicine and human performance

SN - 2375-6314

IS - 5

ER -